Who uses Thermo Fisher Orbitrap Astral?
Orbitrap Astral is a mass spectrometer built for fast, deep proteomics, identifying thousands of proteins per sample in short runs. It's made by Thermo Fisher Scientific. 486 bioRxiv and medRxiv preprints since April 2025 say they used Orbitrap Astral, 212 in the last 6 months. Updated daily (as of Nov 16)
Is Orbitrap Astral use still growing?
Yes: 212 preprints used Orbitrap Astral in Jun–Nov 2026, +101% vs the previous year as a share of all preprints. This is faster than proteomics mass spectrometers overall (+32%).
The last bar is the quarter so far. The % over each year compares it with the year before, as a share of all preprints.
How does Orbitrap Astral compare with other proteomics mass spectrometers?
Orbitrap Astral is third, with 20% of their uses in Jun–Nov 2026, up from 13% the year before. Orbitrap Exploris leads with 44%.
Preprints in the last 6 months
Growth, Jun–Nov 2026 vs Jun–Nov 2025
Orbitrap Exploris+18%
- timsTOF+26%
Orbitrap Astral+101%
- All proteomics mass spectrometers+32%
Which institutions use Orbitrap Astral most?
The institutions using Orbitrap Astral most are Duke University, Max Planck Institute of Biochemistry and University of Copenhagen.
Institutions
Duke University20
Max Planck Institute of Biochemistry16
University of Copenhagen12
Novo Nordisk Foundation Center for Protein Research11
University of Washington9
Where the labs are
The lab's institution and country are the corresponding author's.
Rival platforms, head to head
Latest preprints using Orbitrap Astral
Who started using Orbitrap Astral recently?
108 institutions posted their first preprint using Orbitrap Astral since April 2025 in the last 6 months, including University of Manchester, University of Southern Denmark and University of Ottawa.
University of ManchesterJun 26, 2026
University of Southern DenmarkJun 3, 2026
University of OttawaJun 8, 2026
Westmead Institute for Medical ResearchJun 26, 2026
Guangzhou National LaboratoryJul 1, 2026
Human TechnopoleJul 6, 2026
Fox Chase Cancer CenterJul 17, 2026
University of HelsinkiAug 3, 2026
Murdoch Children’s Research InstituteAug 14, 2026
Goethe University FrankfurtAug 14, 2026
An institution counts as new when its first preprint using Orbitrap Astral since April 2025 was posted in the last 6 months; the date is that first preprint.
What do labs use alongside Orbitrap Astral?
Preprints using Orbitrap Astral most often also use Orbitrap Exploris, NovaSeq X and timsTOF. The count is preprints using both.
What is Orbitrap Astral used for?
Preprints using Orbitrap Astral are most often in biochemistry, cell biology and neuroscience.
Fields
Biochemistry 89Cell biology 58Neuroscience 53Molecular biology 43Microbiology 38Systems biology 34
Where the work was published
- Nature Communications7
- Journal of Proteome Research4
- PROTEOMICS3
- EMBO Molecular Medicine3
- Molecular & Cellular Proteomics3
- Communications Biology2
How we count which preprints use each platform
An AI model reads each preprint in full — its text, its tables and its supplementary files — and lists the products the authors used. A preprint counts for a platform when that record says the lab used it in this work, not when it only analyzed data others made with it or only mentioned it. Each preprint counts once, by its first version, if it was first posted on bioRxiv or medRxiv in April 2025 or later. We read new preprints within days of posting, so the newest ones (through Nov 16, 2026) are already counted, but those days are not complete yet. Six-month counts and growth figures stop at Nov 12, 2026, the last day nearly every preprint has been read, and charts draw a quarter that is still being counted in a paler color. A preprint that used two platforms counts for both. Each title links to the preprint on bioRxiv or medRxiv; we show no preprint text and no author names. Updated daily, most recently on Nov 16, 2026.